David Rawlings, MD, on Research That Supports the Development of Engineered B-cell Therapies
October 17th 2023The director of the Center for Immunity and Immunotherapies at Seattle Children's Research Institute discussed findings from several preclinical studies that could help bring engineered B-cell therapies to clinical trials.
Thomas Povsic, MD, PhD, on Ongoing Research With XC001 Angina Gene Therapy
October 8th 2023The interventional cardiologist and professor, Duke University School of Medicine, discussed other populations that may benefit from XC001 and the challenges and opportunities with a surgical delivery of treatment.